Private Equity Firm Profile
Symmetric Capital’s most common sectors for investment arelife science (16%) and medical products (16%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (70%) and growth capital (31%). In total, Symmetric Capital has invested in 10 US states and 2 different countries.
The Firm’s most common exit type is trade sale (79%). Symmetric Capital’s largest (disclosed) exit occurred in 2015 when it sold BioRx for $210M.
Join Mergr to view Symmetric Capital’s full profile and discover more small private equity firm investors just like it.
M&A Summary
-
M&A Total Activity27
- M&A Buy Activity13
- M&A Sell Activity14
- Total Sectors Invested 10
- Total Countries Invested 2
- M&A Buy/Sell Connections 15
- M&A Advisors 2
Unlimited Searches
